AMRN ($AMRN) Insider Trading & Smart Money Activity

AMRN · Drug Manufacturers - General · Latest filing Jun 26, 2026

$AMRN has 4 insider trades on file. Insiders filed 4 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

AMRN insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AMRN insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 26, 2026	Insider	Aaron BergPresident and CEO	Sell (Tax withholding)	3.20K sh	$52.27K		-1.1%	-13.2%			Read
Jun 26, 2026	Insider	Aaron BergPresident and CEO	Sell (Tax withholding)	3.20K sh	$52.27K		-1.1%	-13.2%			Read
Jun 26, 2026	Insider	Aaron BergPresident and CEO	Buy (Option exercise)	6.25K sh			-1.1%	-13.2%			—
Jun 26, 2026	Insider	Aaron BergPresident and CEO	Buy (Option exercise)	6.25K sh			-1.1%	-13.2%			—

1W / 1M / 6M = how AMRN moved from the trade or filing date.

Insider trading in AMRN: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Aaron Berg	President and CEO	4	—		Jun 26, 2026

Frequently asked questions

What is the latest insider trade in AMRN?

Aaron Berg, President and CEO filed a sell (tax withholding) of 3.20K sh worth $52.27K on Jun 26, 2026.

Other drug manufacturers - general stocks

• $MIRA
• $OGN
• $GRFS
• $BIIB
• $GSK
• $SNY
• $BMY
• $PFE

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.